Vebreltinib

DB16823InvestigationalSmall molecule

Vebreltinib: Overview.

Chemical structure of Vebreltinib
Formula / weight
C20H15F3N8 · 424.391 g/mol (avg)
Also known as
Bozitinib
Code names
APL-101 · CBI-3103 · CBT-101 · PLB-1001

Resolves to

Compound
UNII2WZP8A9VFNCAS1440964-89-5ChEMBLCHEMBL4650443
Structure
InChIKeyQHXLXUIZUCJRKV-UHFFFAOYSA-NSMILESCN1C=C2C=C(C(F)=CC2=N1)C(F)(F)C1=NN=C2C=CC(=NN12)C1=CN(N=C1)C1CC1
Targets
P08581MET

What you can answer from here — as of October 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
23Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Vebreltinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In